Riley et al. [19] showed that BART13-3p could target CAPRIN2, a Wnt signaling enhancer whose over-expression enhances apoptosis, and can maintain EBV persistence during latent infection in B cells. Here, CAPRIN2 is linked to disease arising from reactivation of latent virus.